Drs. Katherine Talcott and Priya Vakharia join to discuss the August 2022 issue of Retinal Physician, found online at http://www.retinalphysician.com. Topics covered pertain to suprachoroidal therapy for macular degeneration, uveitis, and ocular oncology indications.
Relevant Financial Disclosures:
Dr. Sridhar is a consultant for Alcon, DORC, Genentech, and Regeneron. Dr. Talcott is a consultant for Genentech, Regenxbio, and Zeiss. Dr. Vakharia is a consultant for Genentech and Bausch and Lomb.
CME Information
Release: August 5, 2022; expires August 5, 2025
Reviewers: Xuejing Chen, MD, MS
Disclosures: The physician reviewers and Academy staff report no relevant financial disclosures.
Learning Objective: Upon completion of this episode, the listener should be able to describe evolving standards of care for the management of vitreoretinal disorders or the outcomes from recent research and how these impact patient care decisions.
Audience: This activity is intended for retina subspecialists and comprehensive ophthalmologists.
Accreditation: The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Academy of Ophthalmology designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits.TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hardware/Software Requirements: This learning activity requires a current web browser and speaker or headset capable of playing streaming audio.